The Health Management Academy (THMA), a membership-based executive healthcare community founded in 1998, announced its 2026 Cardiovascular and Oncology Forums take place May 6–8, 2026, in Fort Lauderdale, Florida. These two events are closed-door conferences designed to bring together senior executives from leading U.S. health systems and life sciences organizations at a moment of acute pressure on drug availability, supply-chain operations, and reimbursement policy.
The announcement comes as drug shortages in the United States reach historically high levels. A consensus statement from the Oncology Nursing Society documents more than 3,400 new drug shortages since 2000, with active shortages peaking at 323 in the first quarter of 2024, an all-time high. Cancer medications rank among the most vulnerable drug classes, and heavy reliance on foreign sources for active pharmaceutical ingredients continues to expose U.S. supply chains to structural risk. A Vizient analysis cited in the same statement found that U.S. hospitals spent approximately $894 million in labor costs and 20 million staff hours managing shortages in 2023 alone, with 74% of institutions exceeding their allocated budgets.
These pressures intersect with accelerating shifts in reimbursement policy. CMS's 2026 Hospital Outpatient Prospective Payment System final rule expands site-neutral payment reforms and begins the full phase-out of the inpatient-only list by 2028, compelling health systems and manufacturers alike to reassess site-of-care strategies and distribution partnerships. Simultaneously, the 340B program faces compression from Medicare's Drug Price Negotiation Program and HRSA's rebate pilot, creating revenue pressures that affect covered entities' capacity to sustain patient-care programs.
THMA's 2026 Cardiovascular and Oncology Executive Convenings will address these converging challenges directly, with participation from senior executives representing major health systems and life sciences organizations. Topics scheduled for discussion include strategic sourcing and multi-supplier procurement, AI-driven supply forecasting, value-based contracting models aligned to performance outcomes, the policy implications of site-neutral payment and 340B reform, and cross-functional governance structures for clinical and commercial decision-making.
About the Executive Convening Format
THMA's Executive Convening model differs substantially from traditional healthcare conferences. Each forum is deliberately restricted in size, typically 25 to 80 senior executives, and structured to prioritize peer-led discussion over formal presentations. The model draws participation from C-suite leaders at major integrated delivery systems, including institutions such as Mayo Clinic, Cleveland Clinic, Kaiser Permanente, Providence, and Northwell Health, alongside chief executives, strategy officers, and commercial leaders from healthcare technology, medical device, pharmaceutical, and healthcare services organizations.
THMA maintains relationships with more than 2,000 health-system executives and approximately 600 C-suite members across its forums. The organization's convening structure is designed to enable candid conversation on operationally sensitive topics, including supply-chain vulnerability, contracting strategy, and reimbursement reform, in an environment governed by the organization's published guiding principles and code of conduct.
The 2026 Cardiovascular and Oncology Executive Convenings are scheduled for May 6–8, 2026, in Fort Lauderdale, Florida. Industry organizations interested in participation may request more information for each respective event below:
About The Health Management Academy (THMA)
The Health Management Academy is a membership-based executive healthcare community founded in 1998. The organization convenes peer groups of health-system executives and industry leaders through its Executive Convening programs, supports leadership development through talent and professional growth initiatives, and delivers data-driven research and analysis on the challenges facing the U.S. healthcare system. THMA's community encompasses more than 2,000 senior healthcare leader relationships, 600 C-suite members, and 150 or more innovative industry members. To learn more, visit hmacademy.com.
